<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: <z:hpo ids='HP_0001873'>Thrombocytopenia</z:hpo> is a significant and morbid problem in patients with <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematologic malignancy</z:e>, resulting in frequent platelet transfusions and significant resource consumption </plain></SENT>
<SENT sid="1" pm="."><plain>We undertook this study to determine the impact of splenectomy on transfusion requirements in patients with <z:hpo ids='HP_0005558'>chronic leukemia</z:hpo>, <z:hpo ids='HP_0002488'>acute leukemia</z:hpo>, <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo>, and <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Records of 134 patients with <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematologic malignancies</z:e> who underwent splenectomy were reviewed </plain></SENT>
<SENT sid="3" pm="."><plain>Results are reported as mean +/- standard error of the mean </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Mean preoperative (preop) platelet count was 97 +/- 8 K/microL </plain></SENT>
<SENT sid="5" pm="."><plain>A significant rise in platelets, compared with preop, was observed starting on postsplenectomy day 1 (141 +/- 8 K/microL, P &lt; 0.001 versus preop) and persisted through day 7 </plain></SENT>
<SENT sid="6" pm="."><plain>Counts remained significantly elevated at 3 and 6 months and years 1-5 </plain></SENT>
<SENT sid="7" pm="."><plain>In profoundly thrombocytopenic patients (preop levels &lt; 20 K/microL), preop count was 11 +/- 1 K/microL </plain></SENT>
<SENT sid="8" pm="."><plain>A significant postsplenectomy platelet rise persisted for at least 1 year (137 +/- 52 K/microL, P &lt; 0.05 versus preop) </plain></SENT>
<SENT sid="9" pm="."><plain>An increased platelet level was observed in <z:hpo ids='HP_0000001'>all</z:hpo> hematologic subgroups; in the <z:hpo ids='HP_0005558'>chronic leukemias</z:hpo> (n = 58, P &lt; 0.01) and in <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (n = 59, P &lt; 0.001), this reached significance </plain></SENT>
<SENT sid="10" pm="."><plain>Mean platelet transfusions were significantly decreased from preop (3 months preop: 8.6 +/- 2 units) compared with postsplenectomy (3 months postsplenectomy: 5.0 +/- 1 unit, P = 0.03) </plain></SENT>
<SENT sid="11" pm="."><plain>This decrease was even more pronounced in profoundly thrombocytopenic patients (31.6 +/- 10.6 units preop versus 8.9 +/- 4.8 units postoperative, P = 0.01) </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSIONS: In the <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematologic malignancies</z:e>, splenectomy produces a significant and longlasting restoration of platelet levels and a resultant decrease in platelet transfusion requirements </plain></SENT>
<SENT sid="13" pm="."><plain>These beneficial effects of splenectomy hold true even for the most profoundly thrombocytopenic patients </plain></SENT>
</text></document>